Antibody Concentrations Against Pneumococcal Vaccine Serotypes One month after the administration of the 3rd vaccine dose i.e. Month 5 [clinicaltrials_resource:000057dd7c420208c0b09c4fdc3fcf19]
Concentrations were expressed as geometric mean concentration (GMC). The vaccine pneumococcal serotypes assessed include 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Antibody Concentrations Against Pneumococcal Vaccine Serotypes One month after the administration of the 3rd vaccine dose i.e. Month 5 [clinicaltrials_resource:000057dd7c420208c0b09c4fdc3fcf19]
Concentrations were expressed as geometric mean concentration (GMC). The vaccine pneumococcal serotypes assessed include 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F.
Bio2RDF identifier
000057dd7c420208c0b09c4fdc3fcf19
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:000057dd7c420208c0b09c4fdc3fcf19
measure [clinicaltrials_vocabulary:measure]
Antibody Concentrations Against Pneumococcal Vaccine Serotypes
time frame [clinicaltrials_vocabulary:time-frame]
One month after the administration of the 3rd vaccine dose i.e. Month 5
description
Concentrations were expressed ...... 7F, 9V, 14, 18C, 19F, and 23F.
identifier
clinicaltrials_resource:000057dd7c420208c0b09c4fdc3fcf19
title
Antibody Concentrations Agains ...... 3rd vaccine dose i.e. Month 5
@en
type
label
Antibody Concentrations Agains ...... 057dd7c420208c0b09c4fdc3fcf19]
@en